The Macerich Company MAC ← Back to all reports

The Macerich Company

MAC · Real Estate
B ★★★ Hold
Aug 12, 2026 · Score 76 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $24.29
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $21.50 ($20.00–$23.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $27.90
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+14.9%

Type A - The Macerich Company (MAC) 20260812 Stock Analysis

📅 Macerich Key Upcoming Events

🏢 Step 1: Macerich Company Overview & Business Model

Q1-A1. What is Macerich?

Q1-A2. How Does Macerich Make Money?

Q1-A3. Macerich’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Macerich’s Competitors?

Q1-A5. Macerich Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Macerich’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Macerich Have a Durable Economic Moat?

Q2-A2. Is Macerich’s Growth Sustainable?

Q2-A3. How Does Macerich Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Macerich Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Macerich? (Margins & ROIC)

Q3-A3. What Drives Macerich’s Returns? (ROIC Breakdown)

Q3-A4. Are Macerich’s Earnings High Quality?

Q3-A5. Is Macerich’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Macerich Forensic Accounting & Dilution Review

Q4-A1. Does Macerich Have Accounting Red Flags?

Q4-A2. Is Macerich Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Macerich’s Cash Flow?

Q4-A4. Is Macerich Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Macerich Management & Shareholder Alignment

Q5-A1. Can You Trust Macerich’s Management? (Guidance Track Record)

Q5-A2. What Are Macerich Insiders Doing?

Q5-A3. Is Macerich’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Macerich Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Macerich Guidance

Q6-A2. What Is Macerich’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Macerich Catalysts & Price Triggers

Q7-A1. What Could Move Macerich Stock? (Top 3 Catalysts)

Q7-A2. Macerich’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Macerich Fairly Valued? Valuation Analysis

Q8-A1. Macerich’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Macerich vs Peers: Valuation Comparison

Q8-A3. Is Macerich Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Macerich? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Macerich? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Macerich’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Macerich? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Macerich?

Q9-A2. How Sensitive Is Macerich to the Economy?

Q9-A3. Macerich Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Macerich Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Macerich? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Macerich’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Macerich’s High Debt Leverage Its Biggest Weakness?

Q2: Can Macerich’s 16x Forward P/FFO Be Justified by the Path Forward Plan?

Q3: Will the SNO (Signed Not Open) Pipeline Effectively Accelerate Macerich’s NOI Growth?

Q4: How Does Macerich’s Strategy of Non-Recourse Loan Defaults Impact Its Long-Term Solvency?

Q5: Are the Recent Equity and Exchangeable Note Issuances Too Dilutive for Macerich Shareholders?

Q6: Can Macerich’s Class A Assets Offset the Broader Secular Decline in Physical Mall Retail?

Q7: Will the Redevelopment of Scottsdale Fashion Square Deliver the Projected Yields for Macerich?

Q8: Why Is Macerich Executing Acquisitions Like Crabtree and Annapolis During a Deleveraging Phase?

Q9: Does Macerich’s High Dividend Payout Ratio Threaten Its Ability to Fund Essential Redevelopments?

Q10: Is Macerich’s $1.7 Billion Asset Disposition Goal Feasible in the Current High-Interest Rate Environment?